Upper Facial Remodeling With Perlane-L and Dysport
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide data to support combination treatment of the upper
face with Perlane-L® and Dysport™. This study will assess the outcome of upper face
rejuvenation in the temporal fossa; outcome of glabella and/or periorbital regions will also
be assessed as a secondary endpoint.
Phase:
Phase 4
Details
Lead Sponsor:
Beer, Kenneth R., M.D., PA
Collaborator:
Medicis Pharmaceutical Corporation
Treatments:
abobotulinumtoxinA Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA